Gushengtang Holdings Limited (2273.HK)

HKD 31.3

(-1.57%)

EBITDA Summary of Gushengtang Holdings Limited

  • Gushengtang Holdings Limited's latest annual EBITDA in 2023 was 429.9 Million CNY , up 98.85% from previous year.
  • Gushengtang Holdings Limited's latest quarterly EBITDA in 2023 FY was N/A , up 98.85% from previous quarter.
  • Gushengtang Holdings Limited reported an annual EBITDA of 324.21 Million CNY in 2022, up 440.74% from previous year.
  • Gushengtang Holdings Limited reported an annual EBITDA of -62.75 Million CNY in 2021, down -152.69% from previous year.
  • Gushengtang Holdings Limited reported a quarterly EBITDA of 181.21 Million CNY for 2023 Q4, down 0.0% from previous quarter.
  • Gushengtang Holdings Limited reported a quarterly EBITDA of 104.28 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of Gushengtang Holdings Limited (2023 - 2018)

Historical Annual EBITDA of Gushengtang Holdings Limited (2023 - 2018)

Year EBITDA EBITDA Growth
2023 429.9 Million CNY 98.85%
2022 324.21 Million CNY 440.74%
2021 -62.75 Million CNY -152.69%
2020 119.1 Million CNY 231.81%
2019 -89.67 Million CNY 20.07%
2018 -110.45 Million CNY 0.0%

Peer EBITDA Comparison of Gushengtang Holdings Limited

Name EBITDA EBITDA Difference
Aidigong Maternal & Child Health Limited 68.84 Million HKD -524.425%
UMP Healthcare Holdings Limited 161.98 Million HKD -165.402%
Human Health Holdings Limited 104.06 Million HKD -313.115%
EuroEyes International Eye Clinic Limited 292.1 Million HKD -47.175%
Kato (Hong Kong) Holdings Limited 133.61 Million HKD -221.758%
Bamboos Health Care Holdings Limited 52.75 Million HKD -714.86%
Beijing Health (Holdings) Limited -44.19 Million HKD 1072.832%
C-MER Eye Care Holdings Limited 359.88 Million HKD -19.457%
Town Health International Medical Group Limited 53.5 Million HKD -703.544%
Medicskin Holdings Limited 6.77 Million HKD -6244.51%
Hang Chi Holdings Limited 81.58 Million HKD -426.927%